Skip to main content
. 2019 Apr 23;10(30):2911–2920. doi: 10.18632/oncotarget.26885

Figure 3. Receiver operating characteristic (ROC) curve analysis on clinical samples for T790M, L858R and exon 19 indels.

Figure 3

The x-axes show 1-Specificity or the False Positive Rate (FPR), and y-axes show the sensitivity or True Positive Rate (TPR). (A) ROC curves for all three assays for all 110 patient samples. (B) ROC curves for all three targets on M1b/MX patient samples alone.